Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.22.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES    
Net (loss) income $ (84,711) $ 53,759
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:    
Depreciation 16,921 13,629
Amortization of intangibles 16,979 6,209
Non-cash stock-based compensation 15,729 7,159
Non-cash operating lease expense 4,989 3,750
Amortization of convertible debt discount 1,324 1,247
Amortization of debt issue costs 91 88
Gain on investment in and loan receivable from non-consolidated affiliate, net 0 (91,510)
Interest receivable on loan receivable from non-consolidated affiliate 0 (391)
Gain on sale of assets held for sale (2,048) 0
Write-off of COVID-19 PCR testing inventory and equipment 0 6,061
Other adjustments 1,602 790
Changes in assets and liabilities, net    
Accounts receivable, net 854 1,155
Inventories 1,533 3,645
Prepaid lease asset 0 (4,730)
Prepaid and other assets (2,202) (4,681)
Accounts payable, operating lease liabilities, deferred taxes, accrued and other liabilities (17,097) 4,640
Net cash (used in) provided by operating activities (46,036) 820
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchases of marketable securities (56,332) (162,769)
Proceeds from sales and maturities of marketable securities 68,525 26,253
Purchases of property and equipment (18,513) (37,178)
Proceeds from assets held for sale 12,098 0
Business acquisitions, net of cash acquired 0 (419,404)
Loan receivable from non-consolidated affiliate 0 (15,000)
Net cash provided by (used in) investing activities 5,778 (608,098)
CASH FLOWS FROM FINANCING ACTIVITIES    
Repayment of equipment financing obligations (574) (1,892)
Issuance of common stock, net 7,642 8,045
Proceeds from issuance of convertible debt, net of issuance costs 0 334,410
Premiums paid for capped call confirmations 0 (29,291)
Proceeds from equity offering, net of issuance costs 0 418,273
Net cash provided by financing activities 7,068 729,545
Net change in cash, cash equivalents and restricted cash (33,190) 122,267
Cash, cash equivalents and restricted cash, beginning of period 316,827 250,632
Cash, cash equivalents and restricted cash, end of period 283,637 372,899
Reconciliation of cash, cash equivalents and restricted cash to the Consolidated Balance Sheets:    
Cash and cash equivalents 283,637 368,796
Restricted cash, non-current 0 4,103
Total cash, cash equivalents and restricted cash 283,637 372,899
Supplemental disclosure of cash flow information:    
Interest paid 2,143 1,329
Income taxes paid, net 129 114
Supplemental disclosure of non-cash investing and financing information:    
Fair value of common stock issued to fund business acquisition 0 29,174
Equity offering issuance costs included in accrued expenses 0 10,137
Purchases of property and equipment included in accounts payable $ 1,529 $ 3,822